Trials / Completed
CompletedNCT01914380
Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration
PERSEUS - A Prospective Non-interventional Study to Assess the Effectiveness of Aflibercept (Eylea®) in Routine Clinical Practice in Patients With Wet Age-related Macular Degeneration
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 988 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study aims to investigate the effectiveness of Eylea in patients with wet age-related macular degeneration in routine clinical practice in Germany. The study is purely observational, only data from routine treatment are to be collected. The treatment and treatment conditions are solely at discretion of the treating physician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) | Patients will be followed-up for 24 months |
Timeline
- Start date
- 2013-07-29
- Primary completion
- 2017-03-31
- Completion
- 2017-03-31
- First posted
- 2013-08-02
- Last updated
- 2018-03-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01914380. Inclusion in this directory is not an endorsement.